RE:RE:Stepped up their Corporate Presentation GameAs Wino and others suggested HIV liver due to ART is harder to treat.
"First-in-class MOA with an upstream approach to underlying causes of NASH De-risked, late stage clinical program with demonstrated proof-of-concept
Statistically significant results in a harder-to-treat patient population, driving optimism for efficacy in a broader, non-HIV patient population"
I really like these statement.
"120+ years of management experience, R&D engine of expert scientists,5.4M F2/F3NASH Patients in US only in 2019 and by 2030 10.6M F2/F3 NASH Patients" and of course great to see a slide with other NASH players.
They did a much better job advetising the legacy drugs too now get that application filed please.
SPCEO1 wrote: Wino - you should be trying to figure out where/how you collect your consulting check from TH!
That is a first class corporate presentation - what we have been lookng for has finally arrived.
SPCEO1 wrote: Check out the new corporate presenatation - big improvement!
https://www.theratech.com/investisseurs/presentations-et-evenements/ew corporate presentation - big improvement!